UK Markets open in 1 hr 51 mins

Adaptimmune Therapeutics plc (ADAP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.0100-0.0500 (-1.63%)
At close: 04:00PM EST
3.0500 +0.04 (+1.33%)
After hours: 06:12PM EST
Full screen
Trade prices are not sourced from all markets
Previous close3.0600
Bid0.0000 x 21500
Ask0.0000 x 3000
Day's range3.0000 - 3.1390
52-week range3.0000 - 7.3400
Avg. volume852,136
Market cap470.174M
Beta (5Y monthly)1.99
PE ratio (TTM)N/A
EPS (TTM)-1.0020
Earnings date23 Feb 2022 - 28 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est9.17
  • Motley Fool

    2 Cancer Stocks With Absurdly Low Valuations

    The potential for four or more interest rate hikes by the Federal Reserve over the course of 2022 has been weighing heavily on growth stocks of late. Investors are clearly pivoting toward safe havens like value and dividend stocks ahead of this perceived eventuality. Shares of the cancer specialists Adaptimmune Therapeutics (NASDAQ: ADAP) and Clovis Oncology (NASDAQ: CLVS) are both trading at absurdly low valuations following their steep downturns over the past several weeks.

  • Zacks

    4 Biotechs That Could Be Potential Takeover Targets in 2022

    We discuss a few companies like BioMarin (BMRN), Adaptimmune (ADAP), CRISPR Therapeutics (CRSP), and Alnylam Pharmaceuticals (ALNY) with solid product portfolios, deep pipelines which make them attractive candidates for a potential takeover in 2022.

  • Motley Fool

    Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November

    A mix of marketwide headwinds and company-specific events weighed on these three biotech stocks in November.